Degang Yu


Country: China


  1. Mao Y, Xu C, Xu J, Li H, Liu F, Yu D, et al. The use of customized cages in revision total hip arthroplasty for Paprosky type III acetabular bone defects. Int Orthop. 2015;39:2023-30 pubmed publisher
    ..The present study demonstrates that a customised cage may be a promising option for THA revision of severely compromised acetabula. Extended follow-up is necessary to evaluate the long-term performance of this approach. ..
  2. Nie S, Xu J, Zhang C, Xu C, Liu M, Yu D. Salicortin inhibits osteoclast differentiation and bone resorption by down-regulating JNK and NF-?B/NFATc1 signaling pathways. Biochem Biophys Res Commun. 2016;470:61-67 pubmed publisher
    ..Thus, salicortin may be of interest in developments of treatment for osteoclast related diseases. ..
  3. Li X, Feng K, Li J, Yu D, Fan Q, Tang T, et al. Curcumin Inhibits Apoptosis of Chondrocytes through Activation ERK1/2 Signaling Pathways Induced Autophagy. Nutrients. 2017;9: pubmed publisher
    ..We propose that curcumin should be explored further for the prophylactic treatment of osteoarthritis in humans and companion animals. ..
  4. Li J, Huang J, Dai L, Yu D, Chen Q, Zhang X, et al. miR-146a, an IL-1? responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. Arthritis Res Ther. 2012;14:R75 pubmed publisher
    ..miR-146a may contribute to OA pathogenesis by increasing VEGF levels and by impairing the TGF-? signaling pathway through targeted inhibition of Smad4 in cartilage. ..